Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Teva Pharmaceutical Industries ADR (TEVA)

Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,633,314
  • Shares Outstanding, K 1,132,909
  • Annual Sales, $ 15,846 M
  • Annual Income, $ -559,000 K
  • EBIT $ 1,681 M
  • EBITDA $ 2,834 M
  • 60-Month Beta 0.79
  • Price/Sales 1.27
  • Price/Cash Flow 5.07
  • Price/Book 3.16

Options Overview Details

View History
  • Implied Volatility 61.18% ( +0.88%)
  • Historical Volatility 33.62%
  • IV Percentile 98%
  • IV Rank 87.55%
  • IV High 66.03% on 07/10/24
  • IV Low 27.03% on 06/11/24
  • Put/Call Vol Ratio 0.34
  • Today's Volume 18,809
  • Volume Avg (30-Day) 36,860
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 856,437
  • Open Int (30-Day) 652,147

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.67
  • Number of Estimates 5
  • High Estimate 0.69
  • Low Estimate 0.65
  • Prior Year 0.98
  • Growth Rate Est. (year over year) -31.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.15 +7.31%
on 11/18/24
18.25 -5.02%
on 12/04/24
-0.10 (-0.57%)
since 11/06/24
3-Month
16.15 +7.31%
on 11/18/24
19.31 -10.25%
on 11/06/24
-0.75 (-4.15%)
since 09/06/24
52-Week
9.35 +85.35%
on 12/11/23
19.31 -10.25%
on 11/06/24
+7.50 (+76.30%)
since 12/06/23

Most Recent Stories

More News
Teva Pharmaceutical Industries Ltd. Enters Agreement to Divest Teva-Takeda Business Venture in Japan to JKI Co., Ltd.

Teva has agreed to divest its Japanese business, Teva-Takeda, to JKI, focusing on innovative medicines.Quiver AI SummaryTeva Pharmaceutical Industries Ltd. has announced an agreement with JKI Co., Ltd.,...

TEVA : 17.33 (-2.75%)
Teva Pharmaceuticals Reports Positive Phase 3 Results for AJOVY® (fremanezumab) in Reducing Migraine Days in Pediatric Patients Aged 6-17

AJOVY® (fremanezumab) reduces migraine days in children, showing efficacy and safety in a Phase 3 study.Quiver AI SummaryTeva Pharmaceutical Industries has announced positive results from its Phase 3...

TEVA : 17.33 (-2.75%)
Is SoundHound AI a Millionaire-Maker Stock?

A tiny company in a fast-growing industry is a recipe for millionaire-making potential. And with shares up by a whopping 347% year to date as of this writing, SoundHound AI (NASDAQ: SOUN) has been a top...

STLA : 13.65 (+3.10%)
SOUN : 15.01 (+12.60%)
BNPQY : 30.8500 (+1.15%)
TEVA : 17.33 (-2.75%)
FJTSY : 18.5700 (-0.16%)
TEVA Stock Down 10% in a Month: Should You Buy the Dip?

Teva Pharmaceutical Industries Limited’s TEVA stock has declined 10% in a month despite strong third-quarter results announced earlier this month. The company beat estimates for earnings as well as sales....

JNJ : 149.31 (-0.14%)
TEVA : 17.33 (-2.75%)
ABBV : 176.19 (+0.01%)
SNY : 48.46 (-0.10%)
2 Generic Drug Stocks Ready to Surge in 2025

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

LXRX : 0.7051 (+8.48%)
VTRS : 12.72 (-1.32%)
TEVA : 17.33 (-2.75%)
AMGN : 272.58 (-0.64%)
PFE : 25.73 (+0.12%)
TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase

Teva Pharmaceutical Industries TEVA reported third-quarter 2024 adjusted earnings of 69 cents per share, which beat the Zacks Consensus Estimate of 65 cents. Adjusted earnings rose 15% year over year.Revenues...

NVO : 110.77 (+1.79%)
JNJ : 149.31 (-0.14%)
TEVA : 17.33 (-2.75%)
ABBV : 176.19 (+0.01%)
Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

TEVA earnings call for the period ending September 30, 2024.

TEVA : 17.33 (-2.75%)
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies due to report their third-quarter 2024 results this week.The remaining large...

NVO : 110.77 (+1.79%)
VTRS : 12.72 (-1.32%)
TEVA : 17.33 (-2.75%)
GILD : 92.13 (-1.35%)
MRNA : 44.44 (+3.49%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END

NTRB : 4.12 (+1.23%)
NTRBW : 1.6000 (-13.51%)
LLY : 826.71 (+0.13%)
NVS : 101.99 (-0.52%)
TEVA : 17.33 (-2.75%)
AMRX : 8.45 (-2.09%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

NTRB : 4.12 (+1.23%)
NTRBW : 1.6000 (-13.51%)
LLY : 826.71 (+0.13%)
NVS : 101.99 (-0.52%)
TEVA : 17.33 (-2.75%)
AMRX : 8.45 (-2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets,...

See More

Key Turning Points

3rd Resistance Point 18.39
2nd Resistance Point 18.13
1st Resistance Point 17.73
Last Price 17.33
1st Support Level 17.07
2nd Support Level 16.80
3rd Support Level 16.40

See More

52-Week High 19.31
Last Price 17.33
Fibonacci 61.8% 15.51
Fibonacci 50% 14.33
Fibonacci 38.2% 13.15
52-Week Low 9.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar